Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2006 2
2007 5
2008 3
2009 12
2010 7
2011 12
2012 10
2013 12
2014 8
2015 5
2016 9
2017 14
2018 9
2019 9
2020 15
2021 10
2022 8
2023 9
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.
Baccelli F, Leardini D, Muratore E, Messelodi D, Bertuccio SN, Chiriaco M, Cancrini C, Conti F, Castagnetti F, Pedace L, Pession A, Yoshimi A, Niemeyer C, Tartaglia M, Locatelli F, Masetti R. Baccelli F, et al. Among authors: castagnetti f. Hum Genomics. 2022 Sep 19;16(1):40. doi: 10.1186/s40246-022-00414-y. Hum Genomics. 2022. PMID: 36123612 Free PMC article.
Treatment recommendations for chronic myeloid leukemia.
Baccarani M, Castagnetti F, Gugliotta G, Palandri F, Rosti G. Baccarani M, et al. Among authors: castagnetti f. Mediterr J Hematol Infect Dis. 2014 Jan 2;6(1):e2014005. doi: 10.4084/MJHID.2014.005. eCollection 2014 Jan 2. Mediterr J Hematol Infect Dis. 2014. PMID: 24455114 Free PMC article. Review.
Current treatment approaches in CML.
Castagnetti F, Gugliotta G, Soverini S, Baccarani M, Rosti G. Castagnetti F, et al. Hemasphere. 2019 Jun 30;3(Suppl):54-56. doi: 10.1097/HS9.0000000000000201. eCollection 2019 Jun. Hemasphere. 2019. PMID: 35309828 Free PMC article. No abstract available.
Cross-intolerance with bosutinib after prior tyrosine kinase inhibitors for Philadelphia chromosome-positive leukemia: long-term analysis of a phase I/II study.
Cortes JE, Lipton JH, Kota V, Castagnetti F, Assouline S, Brümmendorf TH, Leip E, Viqueira A, Gambacorti-Passerini C. Cortes JE, et al. Among authors: castagnetti f. Haematologica. 2023 Dec 1;108(12):3454-3459. doi: 10.3324/haematol.2022.281944. Haematologica. 2023. PMID: 37439348 Free PMC article. Clinical Trial. No abstract available.
Italian Physicians' Perceptions about the Role of Asciminib in Later Lines Chronic Myeloid Leukemia in Clinical Practice: A GIMEMA Survey.
Breccia M, Piciocchi A, Abruzzese E, Cilloni D, Messina M, Soddu S, Castagnetti F, Stagno F, Fazi P, Iurlo A, Caocci G, Gozzini A, Intermesoli T, D'Adda M, Pane F. Breccia M, et al. Among authors: castagnetti f. J Clin Med. 2023 Aug 13;12(16):5267. doi: 10.3390/jcm12165267. J Clin Med. 2023. PMID: 37629308 Free PMC article.
143 results